Primary Therapy With OKT3 for Biopsy-Proven Acute Renal Allograft Rejection

By Kamath S.   Dean D.   Peddi V.R.   Schroeder T.J.   Alexander J.W.   Cavallo T.   First M.R.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1178-1180

Elsevier

Access to resources Recommend Favorite

Biopsy-proven resolution of steroid-resistant acute rejection with basiliximab therapy in a renal allograft recipient

By Goh H.K.   Lye W.C.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3213-3214

Elsevier

Access to resources Recommend Favorite

Biopsy-Proven Chronic Rejection in Living Donor Kidney Transplantation--Risk Factors and Graft Survival

By Kim S.I.   Kim M.S.   Kim Y.S.   Jeong H.J.   Park K.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 100-100

Elsevier

Access to resources Recommend Favorite

Conversion to rapamycin in renal allograft recipients with biopsy-proven calcineurin inhibitor-induced nephrotoxicity

By Diekmann F.   Waiser J.   Fritsche L.   Dragun D.   Neumayer H.H.   Budde K.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3234-3235

Elsevier

Access to resources Recommend Favorite

Multicenter Trial of the Therapeutic Effect of a Newly Developed Antiplatelet Agent, Satigrel, on Biopsy-Proven Chronic Rejection After Kidney Transplantation

By Teraoka S.   Ota K.   Tanabe K.   Takahashi K.   Toma H.   Yasumura T.   Yoshimura N.   Oka T.   Takahara S.   Okuyama A.   Haba T.   Uchida K.   Sugiyama S.   Ohshima S.   Sato T.   Okazaki H.   Morozumi K.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 266-271

Elsevier

Access to resources Recommend Favorite